Who owns Ironwood Pharmaceuticals?

Key details on Ironwood Pharmaceuticals (Ticker: IRWD)

Who owns Ironwood Pharmaceuticals?

Is IRWD a good stock to own? Find out who bought Ironwood Pharmaceuticals, who sold Ironwood Pharmaceuticals (IRWD) stock, and who holds a large position in Ironwood Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 19.44M $202.58M Sept. 30, 2015
Wellington Management Company 17.70M $184.46M Sept. 30, 2015
Janus Capital Management 15.89M $165.57M Sept. 30, 2015
OrbiMed Advisors 11.23M $116.98M Sept. 30, 2015
Vanguard 8.55M $88.83M Sept. 30, 2015
Ridgeback Capital Investments 6.96M $83.26M Dec. 31, 2011
Rubric Capital Management 6.42M $66.92M Sept. 30, 2015
MORGAN STANLEY 6.31M $76.21M June 30, 2015
BlackRock Fund Advisors 5.86M $61.11M Sept. 30, 2015
T. Rowe Price Associates 5.13M $53.45M Sept. 30, 2015
BVF 4.87M $50.79M Sept. 30, 2015
Bridger Management 4.75M $49.48M Sept. 30, 2015
Sectoral Asset Management 4.64M $57.19M March 31, 2014
STATE STREET CORPORATION 4.07M $42.46M Sept. 30, 2015
State of Wisconsin Investment Board 3.86M $40.27M Sept. 30, 2015
Millennium Management 3.37M $51.63M June 30, 2014
Waddell & Reed Financial 3.27M $32.56M June 30, 2013
Deutsche Bank Aktiengesellschaft 3.27M $32.66M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 3.05M $31.75M Sept. 30, 2015
Capital World Investors^ 2.92M $29.10M June 30, 2013

Who sold Ironwood Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Maverick Capital March 31, 2011 3.39M $47.36M